Contract award · 1 Jun 2026

Live Attenuated Influenza vaccine 2026/2027

UK Health Security Agency awarded “Live Attenuated Influenza vaccine 2026/2027” to Astrazeneca UK Limited for £225m. Awarded without open competition.

No competitionMedical equipment & pharmaceuticalsLondon

Value £225m

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Key facts

Value
£225,408,000
Procedure
Negotiated procedure without prior publication (above threshold)
Sector
Medical equipment & pharmaceuticals · Influenza vaccines (CPV 33651660)
Region
London
Timeline
  1. Contract date1 Jun 2026
  2. Published19 Jun 2026Published 18 days after the contract date

Description

For the supply of Live Attenuated Influenza vaccine 2026/2027

About the supplier

More from UK Health Security Agency

All contracts

More won by Astrazeneca UK Limited

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview